• Sonuç bulunamadı

HPC4BD 2017 workshop foreword and program committee

N/A
N/A
Protected

Academic year: 2021

Share "HPC4BD 2017 workshop foreword and program committee"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

HPC4BD 2017 Foreword

Processing large datasets for extracting information and knowledge has always been a fundamental problem. Today, this problem is further exacerbated, as the data a researcher or a company needs to cope with can be immense in terms of volume, distributed in terms of location, and unstructured in terms of format. Recent advances in computer hardware and storage technologies have allowed us to gather, store, and analyze such large-scale data. However, without scalable and cost effective algorithms that utilize the resources in an efficient way, neither the resources nor the data itself can serve to science and society at its full potential. Analyzing Big Data requires a vast amount of storage and computing resources.

We need to untangle the big, puzzling information we have and while doing this, we need to be fast and robust: the information we need may be crucial for a life-or-death situation. We need to be accurate: a single misleading information extracted from the data can cause an avalanche effect. Each problem has its own characteristic and priorities. Hence, the best algorithm and architecture combination is different for different applications. The HPC4BD workshop aims to bring people who work on data-intensive and HPC in industry, research labs, and academia together to share their problems posed by the Big Data in various application domains and knowledge required to solve them.

We thank all the authors for submitting their high-quality work to HPC4BD and their workshop presentations. We also thank to the program committee members, Sameh Abdullah (KAUST), Mehmet Deveci (Sandia National Laboratories), Tahsin Kurç (Stony Brook University), Siva Rajamanickam (Sandia National Laboratories), A. Erdem Sarıyüce (Sandia National Laboratories), Erik Saule (University of North Carolina Charlotte), Robert Soule (University of Lugano), Oğuz Kaya (ENS Lyon, INRIA), Mahantesh Halappanavar (Pacific Northwest National Laboratory), Hongyang Sun (Vanderbilt University), Ata Türk (Boston University), Bora Uçar (CNRS and LIP, ENS Lyon) . Their reviews helped a lot during the paper selection process. Last but not least, as the organizers, we thank to ICPP Workshop Chair Federico Silla (Universitat Politècnica de Valencia) for his help and making the organization easier for us.

Kamer Kaya, Sabanci University, Turkey Buğra Gedik, Bilkent University, Turkey Ümit V. Çatalyürek, Georgia Tech, USA

HPC4BD 2017 Organizers

xvii xvii

(2)

HPC4BD 2017 Program Committee

Organizers

Kamer Kaya, Sabanci University, Turkey Buğra Gedik, Bilkent University, Turkey Ümit V. Çatalyürek, Georgia Tech, USA

Program Committee Members

Sameh Abdullah, KAUST, Saudi Arabia Mehmet Deveci, Sandia National Laboratories, USA

Tahsin Kurç, Stony Brook University, USA Siva Rajamanickam, Sandia National Laboratories, USA

A. Erdem Sarıyüce, Sandia National Laboratories, USA Erik Saule, University of North Carolina Charlotte, USA

Robert Soule, University of Lugano, Switzerland Oğuz Kaya, ENS Lyon, INRIA, France

Mahantesh Halappanavar, Pacific Northwest National Laboratory, USA Hongyang Sun, Vanderbilt University, USA

Ata Türk, Boston University, USA Bora Uçar, CNRS and LIP, ENS Lyon, France

xviii xviii

Referanslar

Benzer Belgeler

In This study pharmacists clearly stated pharmaceutical care as a effort and time consuming process needing experience stress and overload in their jobs and thus community

The interpretation of the net OD values obtained for NSB Zika virus microplate, NSB background microplate, positive control, negative control and the treatment

From this study, it revealed that the majority of the participants were female and both groups are at risk of contaminated needle stick and sharps injuries. Most of the literature

In this study, we aimed that to optimize the methyldetect method for identfy methylation profile of the following genes BRCA1, BRCA2, APC, RUNX3 and CDH1 thus overall goal is

Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an

Two-Factor Analysis of Variance was applied to the data in order to test whether the difference between the pretest-posttest mean scores of the stu- dents in the experimental

Cavit ATALAR Near East University Şenol BEKTAŞ, Vice President NEU.. Altay BİRAND, TNCSMFE Feyza ÇİNİCİOÔLU,

ıtains the Proceedings of the Papers submitted by 11 May 2003 of the Conference on New Developments in Soil Mechanics and Foundation which has been organised by the Turkish